Antenatal Fetal Testing
|
Non-Stress Test |
| |
Biophysical Profile |
Cytogenetic and Molecular Testing
|
Array CGH |
| |
Ashkenazi Jewish panel/study |
| |
BRAC 1 and BRAC 2 testing |
| |
Fluorescent in situ hybridization (FISH) |
| |
Karyotype analysis |
Fetal Therapy
|
Alloimmune thrombocytopenia |
| |
Congenital adrenal hyperplasia |
| |
Rh isoimmunization |
Invasive Fetal Testing
|
Amniocentesis |
| |
Chorionic villi sampling (CVS) |
| |
Percu. Umbilical Blood Sampling (PUBS) |
|
Genetic Risk Assessment (Counseling)
|
Exposure to medications/toxins |
| |
First/Second trimester screening |
| |
Genetic risks of reproductive technologies |
| |
History of recurrent pregnancy loss |
| |
Paternity testing |
| |
Personal/Family history of cancer |
| |
Personal/Family history of birth defects |
| |
Preconception counseling |
| |
Risk of chromosome anomalies |
Reproductive Genetics
|
Genetic conditions associated with infertility |
Ultrasound
|
3-D & 4-D assisted evaluation of fetus |
| |
Evaluation of cervix with vaginal ultrasound |
| |
Doppler evaluation of fetal circulation |
| |
Fetal echocardiogram assisted by TUI/STIC |
| |
High-resolution detailed fetal ultrasound |
|
